News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Thursday, December 7, 2023
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point
      Perspective > Medscape Rheumatology > The Year in Medicine 2011

      COMMENTARY

      Top Ten Rheumatology Articles of 2011

      Bret S. Stetka, MD

      Disclosures

      December 08, 2011

      What Medscape articles were most popular with rheumatologists this year? An important FDA warning made the list, as did a look at belimumab's role in lupus care. Advances in diagnosing and managing scleroderma drew the readers while an attempt to decipher fibromyalgia had tempers flaring. Have a look at these topics and more in our look back at the most popular issues and articles among Medscape rheumatologist readers in 2011:

      10. Doxycycline for Pain in Osteoarthritis?

      9. How Effective Is CertolizumabP in RA?

      8. Figuring Out Fibromyalgia

      7. Enter, Belimumab

      6. Dosing Prednisone in Polymyalgia Rheumatica

      5. Febuxostat vs Allopurinol: And the Winner Is...

      4. TNF Blockers Get Boxed Warning

      3. A New Biomarker for Scleroderma?

      2. Cyclophosphamide for Scleroderma: Pros and Cons

      And the most popular topic among rheumatologists on Medscape in 2011...

      Comments

      3090D553-9492-4563-8681-AD288FA52ACE
      Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

      processing....

      Feedback
      Help us make reference on Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this article more useful to clinicians.
      Pleasedo not use this form to submit personal or patient medical information or to report adverse drug events. You are encouraged to report adverse drug event information to the FDA.
      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.